Arkema

Hoping for a better ending

28/11/24 -"The Q3 exceeded our expectations and we foresee increased momentum from new capacity in 2024, despite the economic situation. However, our projections for 2025 have been revised downward, primarily ..."

PDF page sample
Pages
59
Language
English
Published on
28/11/24
Download
You may also be interested by these reports :
07/10/26
The FT reports that the European Commission’s pesticide omnibus, which partly mirrors industry lobbying, intends to make approvals unlimited, ease ...
02/10/26
Lower earnings expectations but a positive CMD impression
23/09/26
Johnson Matthey (UK, Reduce) has spent the past few years doing what many industrial conglomerates eventually do: shedding parts of itself until only ...
23/09/26
Weak FY25/26 results (below expectations) – Solid outlook on FY26/27E

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO